ECO gets US approval for Aivlosin – stockmarketwire.com

It follows the recent Canadian approval of this formulation and further extends the marketing reach of Aivlosin, ECO’s patented macrolide antibiotic, which is used for the treatment of respiratory and enteric (gut) diseases in pigs and poultry

Leave a Reply

Your email address will not be published.